Report Detail
Global Lanreotide Market Insights, Forecast to 2025
- RnM3447620 |
- 22 May, 2019 |
- Global |
- 110 Pages |
- QYResearch |
- Pharma & Healthcare
Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome
The global Lanreotide market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Lanreotide market based on company, product type, end user and key regions.
This report studies the global market size of Lanreotide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Lanreotide in these regions.
This research report categorizes the global Lanreotide market by top players/brands, region, type and end user. This report also studies the global Lanreotide market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
IPSEN
Market size by Product
60 mg
90 mg
120 mg
Market size by End User
Hospital
Pharmacy
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Lanreotide market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Lanreotide market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Lanreotide companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Lanreotide submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Lanreotide are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Lanreotide market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Lanreotide Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Lanreotide Market Size Growth Rate by Product
- 1.4.2 60 mg
- 1.4.3 90 mg
- 1.4.4 120 mg
- 1.5 Market by End User
- 1.5.1 Global Lanreotide Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Pharmacy
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Lanreotide Market Size
- 2.1.1 Global Lanreotide Revenue 2014-2025
- 2.1.2 Global Lanreotide Sales 2014-2025
- 2.2 Lanreotide Growth Rate by Regions
- 2.2.1 Global Lanreotide Sales by Regions
- 2.2.2 Global Lanreotide Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Lanreotide Sales by Manufacturers
- 3.1.1 Lanreotide Sales by Manufacturers
- 3.1.2 Lanreotide Sales Market Share by Manufacturers
- 3.1.3 Global Lanreotide Market Concentration Ratio (CR5 and HHI)
- 3.2 Lanreotide Revenue by Manufacturers
- 3.2.1 Lanreotide Revenue by Manufacturers (2014-2019)
- 3.2.2 Lanreotide Revenue Share by Manufacturers (2014-2019)
- 3.3 Lanreotide Price by Manufacturers
- 3.4 Lanreotide Manufacturing Base Distribution, Product Types
- 3.4.1 Lanreotide Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Lanreotide Product Type
- 3.4.3 Date of International Manufacturers Enter into Lanreotide Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Lanreotide Sales by Product
- 4.2 Global Lanreotide Revenue by Product
- 4.3 Lanreotide Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Lanreotide Breakdown Data by End User
6 North America
- 6.1 North America Lanreotide by Countries
- 6.1.1 North America Lanreotide Sales by Countries
- 6.1.2 North America Lanreotide Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Lanreotide by Product
- 6.3 North America Lanreotide by End User
7 Europe
- 7.1 Europe Lanreotide by Countries
- 7.1.1 Europe Lanreotide Sales by Countries
- 7.1.2 Europe Lanreotide Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Lanreotide by Product
- 7.3 Europe Lanreotide by End User
8 Asia Pacific
- 8.1 Asia Pacific Lanreotide by Countries
- 8.1.1 Asia Pacific Lanreotide Sales by Countries
- 8.1.2 Asia Pacific Lanreotide Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Lanreotide by Product
- 8.3 Asia Pacific Lanreotide by End User
9 Central & South America
- 9.1 Central & South America Lanreotide by Countries
- 9.1.1 Central & South America Lanreotide Sales by Countries
- 9.1.2 Central & South America Lanreotide Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Lanreotide by Product
- 9.3 Central & South America Lanreotide by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Lanreotide by Countries
- 10.1.1 Middle East and Africa Lanreotide Sales by Countries
- 10.1.2 Middle East and Africa Lanreotide Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Lanreotide by Product
- 10.3 Middle East and Africa Lanreotide by End User
11 Company Profiles
- 11.1 IPSEN
- 11.1.1 IPSEN Company Details
- 11.1.2 Company Business Overview
- 11.1.3 IPSEN Lanreotide Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 IPSEN Lanreotide Products Offered
- 11.1.5 IPSEN Recent Development
12 Future Forecast
- 12.1 Lanreotide Market Forecast by Regions
- 12.1.1 Global Lanreotide Sales Forecast by Regions 2019-2025
- 12.1.2 Global Lanreotide Revenue Forecast by Regions 2019-2025
- 12.2 Lanreotide Market Forecast by Product
- 12.2.1 Global Lanreotide Sales Forecast by Product 2019-2025
- 12.2.2 Global Lanreotide Revenue Forecast by Product 2019-2025
- 12.3 Lanreotide Market Forecast by End User
- 12.4 North America Lanreotide Forecast
- 12.5 Europe Lanreotide Forecast
- 12.6 Asia Pacific Lanreotide Forecast
- 12.7 Central & South America Lanreotide Forecast
- 12.8 Middle East and Africa Lanreotide Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Lanreotide Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Lanreotide . Industry analysis & Market Report on Lanreotide is a syndicated market report, published as Global Lanreotide Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Lanreotide market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
